Literature DB >> 23616461

Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

H Fricker-Hidalgo1, B Cimon, C Chemla, M L Darde, L Delhaes, C L'ollivier, N Godineau, S Houze, L Paris, D Quinio, F Robert-Gangneux, O Villard, I Villena, E Candolfi, H Pelloux.   

Abstract

Classically, Toxoplasma infection is associated with high levels of specific IgM antibody and a rise in specific IgG levels 1 to 3 weeks later. Atypical IgG seroconversion, without IgM detection or with transient IgM levels, has been described during serologic follow-up of seronegative pregnant women and raises difficulties in interpreting the results. To evaluate the frequency and the characteristics of these atypical cases of seroconversion, an investigation was conducted within the French National Reference Center for Toxoplasmosis, from which 26 cases collected from 12 laboratories belonging to the network were identified. The aim of this work was to retrospectively analyze the results of serologic testing, the treatments administered, and the results of prenatal and postnatal follow-up for these women. In each case, IgG antibodies were detected using both screening and confirmatory tests. IgM antibodies were not detected in 15 cases, and the levels were equivocal or low-positive in 11 cases. The IgG avidity results were low in 16 cases and high in one case. Most of the pregnant women (22/26) were treated with spiramycin from the time that IgG antibodies appeared until delivery. Amniotic fluid was analyzed for Toxoplasma gondii DNA by PCR in 11/26 cases, and the results were negative in all cases. Congenital toxoplasmosis was ruled out in 12/26 newborns. There was no abnormality observed at birth for 10 newborns and no information available for 4 newborns. In conclusion, when the interpretation of serological results is so difficult, it seems cautious to initiate treatment by spiramycin and to follow the pregnant women and their newborns.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23616461      PMCID: PMC3697685          DOI: 10.1128/JCM.00169-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the newVidia analyzer system.

Authors:  Adriana Calderaro; Giovanna Piccolo; Simona Peruzzi; Chiara Gorrini; Carlo Chezzi; Giuseppe Dettori
Journal:  Clin Vaccine Immunol       Date:  2008-05-14

2.  What are the respective host and parasite contributions to toxoplasmosis?

Authors:  Danièle Maubon; Daniel Ajzenberg; Marie-Pierre Brenier-Pinchart; Marie-Laure Dardé; Hervé Pelloux
Journal:  Trends Parasitol       Date:  2008-05-29

Review 3.  Management of Toxoplasma gondii infection during pregnancy.

Authors:  Jose G Montoya; Jack S Remington
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

4.  A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti-toxoplasma IgG avidity test.

Authors:  P Flori; B Bellete; C Crampe; A Maudry; H Patural; C Chauleur; J Hafid; H Raberin; R Tran Manh Sung
Journal:  Clin Microbiol Infect       Date:  2007-12-07       Impact factor: 8.067

5.  LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection.

Authors:  Jacqueline Franck; Yves Jean-François Garin; Henri Dumon
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

6.  Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings.

Authors:  Branko Bobić; Ivana Klun; Marija Vujanić; Aleksandra Nikolić; Vladimir Ivović; Tijana Živković; Olgica Djurković-Djaković
Journal:  J Med Microbiol       Date:  2009-03       Impact factor: 2.472

Review 7.  Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review.

Authors:  Annie Elbez-Rubinstein; Daniel Ajzenberg; Marie-Laure Dardé; Robert Cohen; Aurélien Dumètre; Hélène Yera; Emmanuelle Gondon; Jean-Claude Janaud; Philippe Thulliez
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

Review 8.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

9.  IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women.

Authors:  Ermanno Candolfi; Rebecca Pastor; Rachel Huber; Denis Filisetti; Odile Villard
Journal:  Diagn Microbiol Infect Dis       Date:  2007-03-21       Impact factor: 2.803

10.  Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays.

Authors:  Ingo Curdt; Gerald Praast; Eva Sickinger; Jan Schultess; Iris Herold; Hans Bertram Braun; Stephanie Bernhardt; Gregory T Maine; Darwin D Smith; Stephen Hsu; Heike M Christ; Dominick Pucci; Michael Hausmann; Jörg Herzogenrath
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

View more
  19 in total

1.  Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis.

Authors:  Denis Filisetti; Hélène Yera; Odile Villard; Benoît Escande; Estelle Wafo; Véronique Houfflin-Debarge; Laurence Delhaes; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

2.  Interpretation of the Elecsys Toxo IgG avidity results for very low and very high index: study on 741 sera with a determined date of toxoplasmosis.

Authors:  H Fricker-Hidalgo; C L'Ollivier; C Bosson; S Imbert; S Bailly; C Dard; R Piarroux; L Paris; H Pelloux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-19       Impact factor: 3.267

Review 3.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

5.  Validation of dried blood spots in monitoring toxoplasmosis.

Authors:  Mamdouh M Hegazy; Mona K Hegazy; Manar S Azab; Nairmen Nabih
Journal:  Pathog Glob Health       Date:  2020-05-18       Impact factor: 2.894

6.  Toxoplasma gondii Infection in the United States, 2011-2014.

Authors:  Jeffrey L Jones; Deanna Kruszon-Moran; Scott Elder; Hilda N Rivera; Cindy Press; Jose G Montoya; Geraldine M McQuillan
Journal:  Am J Trop Med Hyg       Date:  2017-12-14       Impact factor: 2.345

Review 7.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

Review 8.  Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy.

Authors:  Aref Teimouri; Sina Mohtasebi; Elham Kazemirad; Hossein Keshavarz
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

9.  Assessment of an In-House Enzyme-Linked Immunosorbent Assay and IgG Avidity Test Based on SAG1 and GRA7 Proteins for Discriminating between Acute and Chronic Toxoplasmosis in Humans.

Authors:  Aref Teimouri; Mohammad Javad Abbaszadeh Afshar; Sina Mohtasebi; Sanaz Jafarpour Azami; Rasoul Alimi; Hossein Keshavarz
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

10.  Toxoplasma gondii infection: seroprevalence and associated risk factors for women of childbearing age in Osun State, Nigeria.

Authors:  Olaniran Olarinde; Oluyomi A Sowemimo; Ting-Wu Chuang; Chia-Mei Chou; Segun O Olasanmi; Kemisola Ikotun; Olaoluwa P Akinwale; Vincent P Gyang; Timothy Nwafor; Adeola Y Olukosi; Jer-Hwa Chang; Chia-Kwung Fan
Journal:  Pathog Glob Health       Date:  2021-07-13       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.